Normal view MARC view ISBD view

Bevacizumab for the treatment of neovascular age related macular degeneration.

Chakravarthy, Usha

Bevacizumab for the treatment of neovascular age related macular degeneration. [electronic resource] - BMJ (Clinical research ed.) Jun 2010 - c2834 p. digital

Publication Type: Comment; Editorial

ISSN: 1756-1833

Standard No.: 10.1136/bmj.c2834 doi

Subjects--Topical Terms:
Aged
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Bevacizumab
Humans
Macular Degeneration--drug therapy
Randomized Controlled Trials as Topic
Ranibizumab

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)